Nesterenko

Nesterenko v. Bolt Biotherapeutics, Inc.

Good Law
United States District Court, Northern District of CaliforniaOctober 3, 20243:24-cv-03985California1,387 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 OLEG NESTERENKO, Case No. 24-cv-03985-JSC Plaintiff,

ORDER RE: MOTION FOR

v. APPOINTMENT AS LEAD PLAINTIFF

AND APPROVAL OF LEAD COUNSEL

BOLT BIOTHERAPEUTICS, INC., et al., Re: Dkt. No. 17 Defendants. 11 12 Plaintiff Oleg Nesterenko brings this putative securities class action against Defendant Bolt Biotherapeutics, Inc. for making materially false and misleading statements and omissions in violation of the Securities Exchange Act. (Dkt. No. 1.)1 Before the Court is Gabe Galioto’s unopposed motion for appointment as lead plaintiff and approval of his selection of lead counsel. (Dkt. No. 17.) Having carefully considered the briefing, the Court concludes oral argument is unnecessary, seeCiv. L. R. 7-1(b), and GRANTS the unopposed motion. Mr. Galioto has demonstrated the largest financial interest in the litigation and made a prima facieshowing he is an adequate class representative. The hearing set for October 10, 2024 is vacated. …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.